NeuBase Therapeutics

YTD

ALL

Why Robinhood?

You can watch NBSE and buy or sell other stocks, ETFs, and their options commission-free!

About NBSE

NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines.

CEO

Todd P. Branning, MBA, CPA

CEOTodd P. Branning, MBA, CPA

Employees

—

Employees—

Headquarters

Pittsburgh, Pennsylvania

HeadquartersPittsburgh, Pennsylvania

Founded

2009

Founded2009

Employees

—

Employees—

NBSE Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.45

52 Week high$0.45

52 Week low

$0.36

52 Week low$0.36

People also own

Based on the portfolios of people who own NBSE. This list is generated using Robinhood data, and it’s not a recommendation.